patients (P<0 001). Whilst there was no significant difference in the relative-T-or B -cell contents of pleural effusions between cancer and non-cancer patients (P >005) spontaneous proliferation of lymphocytes was significantly increased (P >0.01), which led to a lower PHA-stimulated transformation index in pleural effusions from cancer patients than in all other lymphocyte sources examined (P<0 001).
METASTATIC PLEURAL EFFUSIONS of patients suffering from cancer of different organs sometimes contain very high numbers of lymphocytes (Yam, 1967; Lopes Cardozo & Harting, 1972) . Yamagishi et al. (1976) found in patients with bronchogenic carcinoma that good clinical conditions were associated with high percentages of lymphocytes, whereas a deterioration of the clinical status was paralleled by an increase of macrophages in the pleural effusions, suggesting that a high number of lymphocytes is able to limit the extent of the disease for a certain period. Apart from this observation, nothing is known about the immunological importance and function of lymphocytes in lymphocyterich pleural effusions. In these effusions, metastatic cells and lymphocytes appear to live under optimum conditions of metabolism and nutrition (Sauter, 1971) .
Since these cells are accessible and can be studied repeatedly, lymphocytes from metastatic pleural effusions appear to be a good natural model for the study of some aspects of the immunological defence against malignant cells.
For this investigation, we selected pleural effusions rich in lymphocytes. We used various methods to characterize lymphocytes immunologically, and compared lymphocytes from metastatic pleural effusions with those from "benign" pleural effusions, as well as with peripheral blood lymphocytes from both patient groups and from normal controls, in order to evaluate the lymphocyte responses characteristic of malignant effusions.
MATERIALS AND METHODS
Patients.-Twenty-three adult patients with recently diagnosed pleural effusions were examined. Effusions had been prescreened by cytological examinations, and the numbers of lymphocytes had been determined in order to select effusions with 105 or more lymphocytes per ml pleural fluid for the metastatic pleural effusions. The "cancer patients" (n = 16) had cancer of the lung or breast complicated by metastatic effusions to the pleural cavity. Four patients had been irradiated in previous years, and their reactions in the PHA-stimulation assay were not considered, in order to exclude possible longterm effects of radiation on the PHA response (Hoppe et al., 1977) . The "non-cancer patients" (n = 7) had congestive heart failure. Pleural effusions with at least 104 lymphocytes per ml w%Nere selected for this group in order to get a reasonable number of non-metastatic pleural effusions for comparison. The pleural effusions from only 3 patients contained enough lymphocytes to measure the PHA response reliably after a 1 I -year period of sampling in our and neighbouring hospitals. None of the patients had received immunosuppressive chemotherapy.
Twenty-three healthy blood donors served as a control in the standardization of the methods. They ranged in age from 23 to 41 years, with a mean of 30 years. Males predominated (74%).
Separation of lymphocytes and identification of cells.-Blood was taken by routine venepuncture and anticoagulated with preservative-free heparin (20 u/ml). Patients with pleural effusions were asked to change their body positions at short intervals before puncture of the pleural cavity. Pleural fluid was also anticoagulated with preservativefree heparin (20 u/mI).
Mononuclear cells were separated from the peripheral blood on a Ficoll-Hypaque gradient using the method of B0yum (1968 Hepes buffer and 2% L-glutamine at a concentration of 2 x 109 cells/l. 0-2 ml washed sheep red blood cells (SRBC) were absorbed 1:1 with foetal calf serum (FCS) and added to 1 ml suspension of mononuclear cells. Cells were incubated for 5 min at 22°C, pelleted for 5 min at 60 g, and stored at 4°C overnight.
After gentle resuspension, 0-02 ml was placed on a slide, 5 ,lI trypan blue was added, and this mixture was covered with a cover glass. Cells were examined with a Normarsky microscope and classified as: (1) rosetteforming cells (RFC) when at least 3 SRBC attached to their surface, (2) blue-stained non-vital lymphocytes, or (3) non-rosetteforming cells (non-RFC). Monocytes were excluded by nonspecific esterase staining (Aiuti et al., 1975) .
Immunofluorescent staining. Mononuclear cells were resuspended in RPMI 1640 at a concentration of 1010 cells/l, kept for 30 min at 37°C, washed, and incubated for 30 min at 4°C with fluorescein-conjugated monospecific (IgG, IgA, or IgM) antisera from goat supplemented with 0.02% sodium azide. Cells w%Nere washed x 3 with PBS and the pellet resuspended in PBS-glycerol. Two drops were placed on a slide, covered, and examined with an epi-illuminated fluorescence microscope. Cells were classified as surface immunoglobulin-bearing cells (SIgBC) or non-SIgBC (Aiuti et al., 1975; Horwitz & Lobo, 1975) .
PHA -stimulated DNA synthesis.-Under sterile conditions, mononuclear cells were resuspended at a concentration of 109 cells/I in RPMI 1640 supplemented with 15% FCS, 15mM Hepes buffer, 2% L-glutamine, 100 iu/ml penicillin, and 0-1 mg/ml streptomycin. Phytohaemagglutinin (PHA-P from DIFCO, Detroit, Michigan, U.S.A.) was dissolved in 5 ml bidistilled water and passed through a Millipore filter. Mononuclear cells were cultured in microtitre plates and supplemented with 0-025ml aliquots of a 0 025% dilution of PHA-P per ml cell suspension. Cells were incubated in a 500 CO2-air environment at 37°C and 100% relative humidity for 72 h. Six hours before harvesting, 0 5 ,uCi 3H-thymidine was added to each culture. After a total of 78 h, cells were collected on fibreglass filters using an automated cell harvester. The healthy blood donors showed the following values (mean + s.d.): lymphocytes 2-34 + 0-86 x 109/1; RFC 70 9 + 7-5%; SIgBC 10 1+ 3-0o; null cells 19-9 + 2.2%; T-cell/ B-cell ratio: 7 0: 1; TI: 39-2 + 6-6.
RESULTS
Cancer patients had cytologically established metastases to the pleural cavity.
The pleural effusions contained a variable number of malignant cells (0-02-50 x 106/1).
In the non-cancer patients, cancer was excluded by all available diagnostic methods, including a follow-up examination several months after analysis of their effusions. Their pleural effusions contained only benign cells.
The average value of lymphocytes in the venous blood (Table I) for the group of non-cancer patients is normal for this age group (Rosenthal & Steinmann, 1978) . Cancer patients had a slightly, but significantly (P < 0.05) lower average. A 9-fold higher mean lymphocyte count was seen in the pleural effusions of cancer patients (P < 0-001) under the conditions of our selection.
Lymphocyte subpopulations
The average number of T cells (RFC) in peripheral blood of cancer patients (0.905 x 109/1) was slightly lower than in noncancer patients (1.161 x 109/1) but the difference was not significant (P > 0 05). Both values lie in the normal range for this age group (Rosenthal & Steinmann, 1978) .
While the absolute concentration of T cells in pleural effusions of cancer patients was considerably higher, there was no significant difference between non-cancer patients and cancer patients in the relative concentration of T cells (P > 0 2). When the proportion of T cells in peripheral blood was compared with that in pleural effusions, there was no significant difference in the group of cancer patients (P> 0.05) though the proportion was higher in pleural effusions. The effusions of non-cancer patients also revealed a slightly higher proportion of T cells than in their venous blood, but the difference was also not statistically significant (P > 0.2) ( Table II) .
The B-cell (SIgBC) counts in peripheral blood of cancer patients (mean: 0-334 x 109/1) did not differ (P > 0-2) from those of non-cancer patients (mean: 0 340 x 109/1). Both values, however, were higher than in young healthy persons (P < 0-01). Especially was the T-cell/B-cell ratio found to be much lower (Table II) .
Pleural effusions also showed about the same relative concentrations of B cells in cancer patients and non-cancer patients (P > 0-2).
Cancer patients showed slightly lower B-cell proportions in pleural effusions than in venous blood (P > 0.05). A similar difference in non-cancer patients was also not significant (P > 041) (Table II) .
We found a lower proportion of markersilent cells (so-called "null" cells) (Non-RFC and Non-SIgBC) in the lymphocytes in the venous blood and pleural effusions of cancer and non-cancer patients than in young healthy persons (P < 0.01). Venous blood of non-cancer patients especially contained few null cells (Table II) .
Response to PHA Lymphocytes from peripheral blood of cancer and non-cancer patients revealed lower transformation indices (TI) than in young healthy donors (P < 0.01) but were indistinguishable from those of healthy persons of the same age group (Yamamura, 1.973; Barnes et al., 1975) . Lymphocytes from pleural effusions from noncancer patients showed even lower TIs (P < 0-001).
The lymphocytes from the venous blood and the pleural effusions of cancer patients clearly showed higher rates of DNA synthesis in the unstimulated state than lymphocytes from both blood and effusions of non-cancer patients (P < 0-01; Table   III ). Consequently, cancer patients' pleural effusions had the lowest TI of all the lymphocyte sources.
Proteins and immunoglobulins
Cancer patients showed higher levels of (Steinmann, unpublished) . In patients in whom a pleural effusion has been acquired for a reason other than cancer, lymphocyte-rich pleural effusions are only occasional. This fact leads to the hypothesis that the malignant cells themselves were responsible for the gathering of lymphocytes, and also that they attracted certain subpopulations (Djeu et al., 1976) .
In metastatic pleural effusions from cancer patients, the distribution of B, T, and null lymphocytes was found to be nearly identical to that in the group of patients with benign diseases complicated by pleural effusions. There was a slight but not significant tendency for T cells to occur in higher numbers in metastatic pleural effusions. This does not confirm the report of Djeu et al. (1976) that the lymphocytes in metastatic pleural effusions were predominantly T cells. This discrepancy might be due to the use of a different RFC assay or to contamination by macrophages or tumour cells in the effusions examined by these authors.
In venous blood of cancer patients, we found a decreased percentage of RFC, which might correspond to a lower T-cellmediated immune competence than in patients with benign diseases and healthy persons in the same age group. This observation agrees with previous reports (Wybran & Fudenberg, 1973; Oldham et al., 1976) . In contrast, there were no significant differences between cancer and non-cancer patients in the number of B cells in venous blood anid pleural effusions. This agrees with the observatioin that cancer patients show no detectable evidence of decreased immunoglobulin synthesis (Aizawa & Southam, 1960) .
The peripheral B-cell counts of both cancer patients and non-cancer patients were slightly higher than in younger healthy volunteers, probably due to the greater age.
We found higher levels of proteins and immunoglobulins in metastatic pleural effusions of cancer patients than in noncancer patients, which did not parallel the B-cell counts in these effusions, suggesting that the Igs in the effusions of cancer patients were not only produced by the B cells in these effusions. The lower level of Ig in the serum of the cancer patients with pleural effusions than in non-cancer patients also supports the hypothesis of an intensive transport of Ig from the serum to the pleural effusion. It would be of interest to analyse why these antibodies are so ineffective in the defence of malignant cells (Mitchison, 1977) .
PHA-stimulated DNA synthesis in blood lymphocytes of cancer patients and other patients has already been investigated by numerous research groups (Barnes et al., 1975; Han & Takita, 1972; Hoppe et al., 1977; Pary & Bone, 1973; Rees et al., 1975; Reis et al., 1977; Robinson et al., 1974; Whitcomb & Parker, 1977) . Most of the authors found that PHA-stimulated DNA synthesis in blood lymphocytes of patients with early-stage cancer was reduced slightly if at all. A clear reduction in DNA synthesis was not found until preterminal stages and after radiation therapy. We also did not observe a significant difference in DNA synthesis by blood lymphocytes between cancer patients and non-cancer patients. On the other hand, we found a significantly increased rate of spontaneous DNA synthesis in the lymphocytes of both peripheral blood and pleural effusions from cancer patients.
Several years ago, Lopes Cardozo & Harting (1972) described the PHAinduced blast transformation of lymphocytes from metastatic pleural effusions. In contrast to our study, they used only morphological criteria of blast transformation, which they reported was gener-ally good, even when the patients had been treated with chemotherapeutic agents. In our study, the lymphocytes from malignant pleural effusions showed a distinctly smaller increase in the rate of DNA synthesis in response to PHA than lymphocytes from benign pleural effusions. This difference was even greater when the lymphocytes of malignant pleural effusions were compared with blood lymphocvtes. The transformation index (TI) of lymphocytes of malignant pleural effusions was 30%0 of the TI of lymphocytes from benign pleural effusions, 25% of the TI of blood lymphocytes from the same cancer patients, and 16 % of the TI of blood lymphocytes from non-cancer patients.
The low TI of the lymphocytes from metastatic pleural effusions in our studies was influenced by the relatively high rate of spontaneous DNA synthesis. Since T lymphocytes respond to stimulation by allogeneic antigens (Clot et al., 1975) stimulation by tumour antigens or by other antigens in cancer-associated diseases might be responsible for the high rate of spontaneous DNA synthesis, since the rate of spontaneous synthesis by blood lymphocytes from cancer patients was also high. This hypothesis is supported by findings of Robinson et al. (1974) , who studied the stimulation of blood lymphocytes by tumour cells from pleural effusions, and found a relatively low degree of additional stimulation by PHA.
The rate of PHA-stimulated DNA synthesis in lymphocytes from benign pleural effusions was also relatively low, suggesting additional cancer independent factors suppressing the PHA response in pleuraleffusion lymphocytes. Robinson et al. (1974) considered the possibility of a factor in pleural effusions that could inhibit the stimulation of lymphocytes. This factor was speculative, but might be similar to the one in mouse ascites, which prolongs the survival of allografts (Biran et al., 1969) . While our immunological characterization of lymphocytes in lymphocyte-rich pleural effusions of cancer and non-cancer patients did not show any major differences in relative B-and T-cell contents, the analysis of the more functional parameters spontaneous DNA synthesis, PHAstimulated DNA synthesis, and Ig content revealed an enhanced activity of lymphocytes of both T and B lineage in metastatic pleural effusions.
